date,title,source
Oct-30-18,"Audentes Therapeutics to Release Third Quarter 2018 Financial Results and Provide Corporate Update on Tuesday, November 6, 2018",PR Newswire
Nov-05-18,Audentes Therapeutics Board of Directors Appoints Co-Founder and Chief Executive Officer Matthew R. Patterson as Chairman,PR Newswire
Nov-06-18,Audentes Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-06-18,Audentes Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update,PR Newswire
Nov-07-18,Audentes Therapeutics to Participate in Upcoming Investor Conferences,PR Newswire
Nov-09-18,"Recent Analysis Shows Audentes Therapeutics, Endocyte, Bluerock Residential Growth REIT, Air Products and Chemicals, BWX Technologies, and Modine Manufacturing Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Nov-12-18,These Biopharmas Could Cure Genetic Diseases  At $5 Million Apiece,Investor's Business Daily
Nov-16-18,Edited Transcript of BOLD earnings conference call or presentation 6-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Dec-07-18,Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),PR Newswire
